Veterinary Medicines

Nobivac Pi, Lyophilisate and Solvent for Suspension for Injection for Dogs

Authorised
  • Canine parainfluenza virus, strain Cornell, Live
Download as PDF

Product identification

Medicine name:
Nobivac Pi, Lyophilisate and Solvent for Suspension for Injection for Dogs
Nobivac PI, lyofilisaat en suspendeervloeistof voor suspensie voor injectie bij honden.
Active substance:
  • Canine parainfluenza virus, strain Cornell, Live
Target species:
  • Dog
Route of administration:
  • Subcutaneous use

Product details

Active substance and strength:
  • Canine parainfluenza virus, strain Cornell, Live
    5.50
    log10 tissue culture infective dose 50
    /
    1.00
    Dose
Pharmaceutical form:
  • Lyophilisate and solvent for suspension for injection
Withdrawal period by route of administration:
  • Subcutaneous use
    • Dog
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI07AD08
Legal status of supply:
This information is not available for this product.
Authorisation status:
  • Valid
Authorised in:
  • Netherlands
Package description:
  • (ID4): 1 Box with 50 Box with (1 Bottle (Glass) with 1 Dose and 1 Bottle (Glass) with 1 millilitre(s)) (50 Dose, 50 millilitre(s))
  • (ID3): 1 Box with 25 Box with (1 Bottle (Glass) with 1 Dose and 1 Bottle (Glass) with 1 millilitre(s)) (25 Dose, 25 millilitre(s))
  • (ID2): 1 Box with 10 Box with (1 Bottle (Glass) with 1 Dose and 1 Bottle (Glass) with 1 millilitre(s)) (10 Dose, 10 millilitre(s))
  • (ID1): 1 Box with 5 Box with (1 Bottle (Glass) with 1 Dose and 1 Bottle (Glass) with 1 millilitre(s)) (5 Dose, 5 millilitre(s))

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Immunological veterinary medicinal product application (Article 13d of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Intervet Nederland B.V.
Marketing authorisation date:
Manufacturing sites for batch release:
  • INTERVET INTERNATIONAL B.V.
Responsible authority:
  • Medicines Evaluation Board
Authorisation number:
  • REG NL 10056
Date of authorisation status change:
Reference member state:
  • Germany
Procedure number:
  • DE/V/0286/001
Concerned member states:
  • Austria
  • Belgium
  • Cyprus
  • Czechia
  • Denmark
  • Estonia
  • Finland
  • Greece
  • Ireland
  • Latvia
  • Lithuania
  • Luxembourg
  • Netherlands
  • Norway
  • Portugal
  • Slovenia
  • Sweden
  • United Kingdom (Northern Ireland)

Documents

Summary of Product Characteristics

English (PDF)
Published on: 28/01/2022
Download

Combined File of all Documents

This document does not exist in this language (English). You can find it in another language below.
Dutch (PDF)
Published on: 8/02/2022
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."